Calliditas Therapeutics AB (publ)
CALT · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $797 | $810 | $974 | $787 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $317 | $259 | $188 | $233 |
| Inventory | $40 | $29 | $20 | $16 |
| Other Curr. Assets | $0 | $76 | $93 | $205 |
| Total Curr. Assets | $1,154 | $1,099 | $1,275 | $1,036 |
| Property Plant & Equip (Net) | $59 | $65 | $54 | $56 |
| Goodwill | $48 | $48 | $49 | $0 |
| Intangibles | $424 | $424 | $431 | $477 |
| Long-Term Investments | $27 | $25 | $24 | $21 |
| Tax Assets | $35 | $27 | $68 | $23 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $593 | $589 | $625 | $576 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,747 | $1,688 | $1,901 | $1,612 |
| Liabilities | – | – | – | – |
| Payables | $151 | $101 | $101 | $67 |
| Short-Term Debt | $0 | $0 | $13 | $0 |
| Tax Payable | $0 | $0 | $6 | $0 |
| Deferred Revenue | $0 | $0 | $6 | $0 |
| Other Curr. Liab. | $279 | $307 | $288 | $278 |
| Total Curr. Liab. | $430 | $408 | $407 | $345 |
| LT Debt | $1,008 | $1,017 | $967 | $770 |
| Deferred Rev, NC | $26 | $30 | $27 | $21 |
| Deferred Tax Liab, NC | $37 | $35 | $83 | $41 |
| Other NC Liab. | $166 | $78 | $150 | $82 |
| Total NC Liab. | $1,211 | $1,160 | $1,159 | $915 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $26 | $30 | $27 | $29 |
| Total Liabilities | $1,640 | $1,568 | $1,566 | $1,259 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | $0 | $0 | -$2,306 | $0 |
| AOCI | $0 | $118 | -$5 | $350 |
| Other Equity | $104 | $0 | $2,643 | $0 |
| Total Equity | $107 | $120 | $335 | $352 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,747 | $1,688 | $1,901 | $1,612 |
| Net Debt | $211 | $206 | $5 | -$17 |